Statistics cookies

These cookies collect information about your use of the website, such as webpages visited and any error messages; they do not collect personally identifiable information, and the information collected is aggregated such that it is anonymous. Performance cookies are used to improve how a website works.
Google analytics Privacy Policy

Marketing cookies

These cookies are used to deliver advertisements more relevant for you, limit the number of times you see an advertisement; help measure the effectiveness of the advertising campaign; and understand people’s behavior after they view an advertisement.
Pardot Privacy Policy | Oktopost Privacy Policy | MRP Privacy Policy | AccountInsight Privacy Policy | Triblio Privacy Policy

Cybersecurity in Life Sciences

Innovate and share data while securing intellectual property

Find out more >

Digital Security Magazine

Combine artificial intelligence and cybersecurity for the greater good

Cybersecurity for Life Sciences organizations: Research and development with peace of mind

The key to innovation in life sciences is set around data. Collecting, analyzing and sharing valuable information between researchers paves the way to excellence. To gain efficiency, pharmaceutical organizations are adopting innovative technologies, such as Cloud or connected medical devices, that will help them optimize their supply chain.

Enhancing life sciences cybersecurity with a specialized partner

In today’s more and more interconnected world, life sciences companies need to adopt the right processes and technologies to get closer to the market and become more competitive.

Atos has led several projects in the pharmaceutical field, each requiring IT and operational technology (OT) knowledge to protect intellectual property.

Proven use cases

Expert teams in life sciences support security projects. Connected medical device assessment, supply chain protection, security audit and traceability.

Global capabilities

Extensive knowledge base shared through 15 SOCs worldwide with 6000+ highly experienced and certified security professionals.

Cybersecurity advisor

From assessment to deployment, services and products for tailored cybersecurity operations that adhere to your local regulations.

Product vision

Own developed and complementary products for a tailored experience and a comprehensive security platform.

End-to-end cybersecurity for life sciences solutions

Atos delivers robust, comprehensive cybersecurity solutions that protect life sciences organizations on any device and across different environments (IT/OT/IoT), saving operational downtime.

Trusted digital identities

Deliver a personal trusted identity to researchers for their everyday practices with public key infrastructure (PKI) solutions.

Digital signature

Ensure the integrity of signed documents and verify the identity of the signee (researcher, partner, administration).

Prescriptive security

Deploy specific OT security operations centres (SOC) capabilities for secure production IT (SCADAs, PLCs, HMIs, embedded IT devices etc.).

Identity and access management

Implement strong authentication to sensitive information and manage staff and third party (researchers, manufacturers, outsourcers) access.

Connected medical devices security

Ensure the right protection measures are in place on medical devices and ensure data stays confidential, whether at rest or in motion.

Cloud security

Protect intellectual property and gain visibility on all your environments, especially in the cloud.

What our customers say about us

Costly downtime in the supply chain, such as when a user types the wrong password in applications, impacts production. This worldwide pharmaceutical company wanted to implement biometric authentication for drugs manufacturing enterprise system (MES) in shop floors to ease the process and increase security.

They selected Evidian Enterprise SSO and Authentication manager, with a wearable biometric solution for handsfree strong authentication.

The company reduced its IT costs and, with improved productivity, additional drugs were produced, resulting in improved return on investment.